Literature DB >> 20386875

[Premature immunosenescence: a pathogenetic factor in Alzheimer's disease?].

E Richartz-Salzburger1, E Stransky, C Laske, N Köhler.   

Abstract

While the familial form of Alzheimer's disease (AD) is known to be entirely inherited, the etiopathogenesis of the most common late-onset form of Alzheimer's disease still remains unresolved. Among various factors, aging seems to be one of the most prominent risk factors. Moreover, a large body of evidence points to the contribution of immunological alterations in AD. The involvement of inflammatory factors in the etiopathology has been widely discussed. Moreover, an impairment of certain immune responses in AD has been observed. Presumably, premature immunosenescence may lead to inadequate immune reactions. Against this background, the development of different immunotherapeutic strategies seems to be a promising challenge for future research.

Entities:  

Mesh:

Year:  2010        PMID: 20386875     DOI: 10.1007/s00115-009-2918-7

Source DB:  PubMed          Journal:  Nervenarzt        ISSN: 0028-2804            Impact factor:   1.297


  29 in total

1.  Mitochondrial DNA damage as a mechanism of cell loss in Alzheimer's disease.

Authors:  S M de la Monte; T Luong; T R Neely; D Robinson; J R Wands
Journal:  Lab Invest       Date:  2000-08       Impact factor: 5.662

2.  Telomere dysfunction of lymphocytes in patients with Alzheimer disease.

Authors:  Jianmin Zhang; Qingli Kong; Zhenxin Zhang; Pingjiang Ge; Denian Ba; Wei He
Journal:  Cogn Behav Neurol       Date:  2003-09       Impact factor: 1.600

Review 3.  Inflammation, autotoxicity and Alzheimer disease.

Authors:  P L McGeer; E G McGeer
Journal:  Neurobiol Aging       Date:  2001 Nov-Dec       Impact factor: 4.673

Review 4.  Inflammation and Alzheimer's disease.

Authors:  H Akiyama; S Barger; S Barnum; B Bradt; J Bauer; G M Cole; N R Cooper; P Eikelenboom; M Emmerling; B L Fiebich; C E Finch; S Frautschy; W S Griffin; H Hampel; M Hull; G Landreth; L Lue; R Mrak; I R Mackenzie; P L McGeer; M K O'Banion; J Pachter; G Pasinetti; C Plata-Salaman; J Rogers; R Rydel; Y Shen; W Streit; R Strohmeyer; I Tooyoma; F L Van Muiswinkel; R Veerhuis; D Walker; S Webster; B Wegrzyniak; G Wenk; T Wyss-Coray
Journal:  Neurobiol Aging       Date:  2000 May-Jun       Impact factor: 4.673

Review 5.  Microglial interaction with beta-amyloid: implications for the pathogenesis of Alzheimer's disease.

Authors:  M E Bamberger; G E Landreth
Journal:  Microsc Res Tech       Date:  2001-07-15       Impact factor: 2.769

6.  Diminished production of proinflammatory cytokines in patients with Alzheimer's disease.

Authors:  E Richartz; A Batra; P Simon; H Wormstall; M Bartels; G Buchkremer; K Schott
Journal:  Dement Geriatr Cogn Disord       Date:  2005-01-25       Impact factor: 2.959

Review 7.  Neuroautoimmunity: pathogenic implications for Alzheimer's disease.

Authors:  V K Singh
Journal:  Gerontology       Date:  1997       Impact factor: 5.140

Review 8.  The immunopathology of Alzheimer's disease and some related disorders.

Authors:  R N Kalaria
Journal:  Brain Pathol       Date:  1993-10       Impact factor: 6.508

9.  Mitochondria, mitochondrial DNA and Alzheimer's disease. What comes first?

Authors:  M Mancuso; D Orsucci; G Siciliano; L Murri
Journal:  Curr Alzheimer Res       Date:  2008-10       Impact factor: 3.498

Review 10.  Inflammaging as a prodrome to Alzheimer's disease.

Authors:  Brian Giunta; Francisco Fernandez; William V Nikolic; Demian Obregon; Elona Rrapo; Terrence Town; Jun Tan
Journal:  J Neuroinflammation       Date:  2008-11-11       Impact factor: 8.322

View more
  2 in total

1.  Alpha-synuclein levels in blood plasma decline with healthy aging.

Authors:  Niklas K U Koehler; Elke Stransky; Mirjam Meyer; Susanne Gaertner; Mona Shing; Martina Schnaidt; Maria S Celej; Thomas M Jovin; Thomas Leyhe; Christoph Laske; Anil Batra; Gerhard Buchkremer; Andreas J Fallgatter; Dorothee Wernet; Elke Richartz-Salzburger
Journal:  PLoS One       Date:  2015-04-06       Impact factor: 3.240

2.  Reduced β-amyloid pathology in an APP transgenic mouse model of Alzheimer's disease lacking functional B and T cells.

Authors:  Claudia Späni; Tobias Suter; Rebecca Derungs; Maria Teresa Ferretti; Tobias Welt; Fabian Wirth; Christoph Gericke; Roger M Nitsch; Luka Kulic
Journal:  Acta Neuropathol Commun       Date:  2015-11-11       Impact factor: 7.801

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.